Amendment of regulation 110 (revocation, variation and suspension of certificate of registration)U.K.
102.—(1) Regulation 110 M1 is amended as follows.
[F1(2) In paragraph (7) for “established in the European Union” substitute—
“established in—
(a)the United Kingdom; or
(b)in relation to a COR(NI), either the United Kingdom or the European Union,
in accordance with the requirements of these Regulations.”.]
[F2(2A) After paragraph (8A) insert—
“(8B) Condition I is that the licensing authority thinks that the revocation, variation or suspension is necessary or expedient in light of the Protocol on Ireland/Northern Ireland in the withdrawal agreement.”.]
(3) Omit paragraph (10).
Textual Amendments
F1Reg. 102(2) substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 80(a)
F2Reg. 102(2A) inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 80(b)
Commencement Information
I1Reg. 102 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1
Marginal Citations
M1Regulation 110 was amended by S.I.2013/1855.